...
首页> 外文期刊>Infection and immunity >Characterization of protective T cells in the acquired response to Leishmania donovani in genetically determined cure (H-2b) and noncure (H-2d) mouse strains.
【24h】

Characterization of protective T cells in the acquired response to Leishmania donovani in genetically determined cure (H-2b) and noncure (H-2d) mouse strains.

机译:在基因确定的治愈(H-2b)和非治愈(H-2d)小鼠品系中,保护性T细胞在对利什曼原虫的后天应答中的表征。

获取原文
           

摘要

The response to reinfection with Ethiopian Leishmania donovani was evaluated in genetically determined noncure (H-2d) B10.D2 mice that are able to resolve infection due to sublethal irradiation pretreatment after inoculation with a low parasite dose and in C57BL/10 mice that demonstrate the genetically determined cure (H-2b) response to L. donovani. It was found that after resolution of primary infection, C57BL/10 (cure) mice and sublethally irradiated B10.D2 (noncure) mice were resistant to rechallenge with L. donovani. Noncure mice inoculated with a low dose of amastigotes were not, however, solidly immune to reinfection. Adoptive-cell transfer experiments were then done to determine the T-cell subset that was associated with resistance to reinfection, and thus the development of immunity, in sublethally irradiated B10.D2 noncure mice and in C57BL/10 cure mice. T-cell-enriched preparations from spleens of immune donors were treated with subset-specific antibodies and complement prior to adoptive transfer in unprimed recipients. The results of the adoptive transfer experiments provide evidence that the genetically determined cure (H-2b) response in C57BL/10 mice and the cure response in genetically determined noncure (H-2d) B10.D2 mice brought about by sublethal irradiation pretreatment are mediated primarily by an L3T4+ Lyt-2- T cell.
机译:在经过基因确定的非治愈性(H-2d)B10.D2小鼠中评估了对埃塞俄比亚利什曼原虫donovani再感染的反应,该小鼠能够以低寄生虫剂量接种后进行亚致死性辐射预处理来解决感染,而在C57BL / 10小鼠中证明了这种效果基因确定的治愈(H-2b)对L. donovani的反应。发现原发感染消退后,C57BL / 10(治愈)小鼠和亚致死剂量照射的B10.D2(非治愈)小鼠对多诺尼乳杆菌具有抵抗性。但是,未接种小剂量变形虫的非治愈小鼠对再次感染没有完全的免疫力。然后进行过继性细胞转移实验,以确定在不完全暴露的B10.D2非治愈小鼠和C57BL / 10治愈小鼠中与再感染抗性相关的T细胞亚群,从而确定与免疫力的发展相关。来自免疫供体脾脏的富含T细胞的制剂在未初次接受者中过继转移之前用亚群特异性抗体和补体处理。过继转移实验的结果提供了证据,证明了通过亚致死剂量辐射预处理引起的C57BL / 10小鼠遗传确定的治愈(H-2b)应答和遗传确定的非治愈(H-2d)B10.D2小鼠的治愈应答。主要由L3T4 + Lyt-2-T细胞引起。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号